跳至主要内容
临床试验/NCT02868021
NCT02868021已完成不适用

Blood Flow Restriction Exercise for Older Adults Undergoing Knee Replacement Surgery

University of Florida2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2016年12月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Changes between the two group assessed by muscle strength

研究概览

简要总结

This pilot study will investigate the effects of blood flow restriction (BFR) exercise for up to 4-6 weeks prior to total knee arthroplasty (TKA) surgery in older patients to measure clinical outcomes such as strength, lower extremity function, and pain.

详细描述

The purpose of this study is to test the feasibility and efficacy of a low-resistance exercise protocol with blood flow restriction (BFR) using a tourniquet in the preoperative period of patients awaiting TKA. BFR exercise is a new exercise method that has not been studied in the perioperative period. The investigators will compare our intervention to a no-exercise group up to 4 - 6 weeks prior to surgery to determine if this type of exercise is feasible in the preoperative period and if BFR exercise will improve functional, physiological, and molecular outcomes when compared to patients without exercise.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • are scheduled for elective TKA for osteoarthritis
  • are scheduled for unilateral joint replacement surgery only
  • are able to give consent and follow instructions
  • are willing to complete up to 15 study visits

排除标准

  • patients below the age of 55 years old
  • patients over the age of 80 years old
  • patients who live in a radius greater than 45 miles from the University of Florida (a feasible distance to allow for transportation to and from the clinical center for assessment visits)
  • patients with impaired cognitive function and mental disease, (e.g. diagnosis of Alzheimer's disease)
  • patients with paraplegia/extremity amputation
  • patients with end stage renal disease requiring dialysis
  • patients with uncontrolled diabetes and insulin-dependent diabetes
  • patients with uncontrolled cardiovascular disease e.g. (Classes of Heart Failure (CHF) New York Heart Association (NYHA) class 3 or higher, BP > 180/110 mmHg)
  • patients with severe pulmonary disease requiring continuous oxygen therapy
  • patients with active neoplasm
  • patients with peripheral vascular disease or deep vein thrombosis (within the last 3 years)
  • patients with structured exercise/Physical Therapy(PT)/Occupational Therapy (OT)/fitness program enrollment within 12 weeks prior to surgery and/or more than 2 hours per month on gym/fitness room exercises
  • patients with BMI greater than 40 kg/m2
  • patients with opioid use of more than 30 mg Morphine-equivalents per day
  • patients with chronic oral steroid use
  • patients with chronic anticoagulation (e.g. Plavix, Warfarin)
  • patients with planned postoperative admission to a skilled nursing/inpatient rehab facility
  • patients with ipsilateral joint disease involving hip, ankle or spine
  • neurologic or other etiology of quadriceps wasting
  • surgery within less than 4 weeks
  • patients with comorbidities that the PI judges as not suitable for the study
  • patients with a minimal mental status (MMSE) score below 24

研究组 & 干预措施

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Six-minute walk (SMW) (Behavioral)

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Numerical pain scale (Behavioral)

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Self-assessed function (Behavioral)

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Muscle biopsies (Procedure)

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Strength testing (Device)

NO-EX group

Placebo Comparator

Subjects allocated to the No Exercise (NO-EX) group will undergo: Strength testing, Short Physical Performance Battery (SPPB), Six-minute walk (SMW), Numerical pain scale, Self-assessed function and Six-minute walk (SMW) test. Intra-op muscle biopsies.

干预措施: Short Physical Performance Battery (SPPB) (Behavioral)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Strength testing (Device)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Short Physical Performance Battery (SPPB) (Behavioral)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Six-minute walk (SMW) (Behavioral)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Numerical pain scale (Behavioral)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Self-assessed function (Behavioral)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Muscle biopsies (Procedure)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Determination of 1 Repetition Maximum (1-RM) (Device)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Blood flow restriction exercise (Device)

EX-BFR group

Experimental

Subjects allocated to the EX-BFR group will undergo baseline strength testing, Short Physical Performance Battery (SPPB), Numerical pain scale, Six-minute walk (SMW), Self-assessed function, and determination of 1 Repetition Maximum (1-RM). Blood flow restriction exercise, Borg Category Ratio 10 (Borg CR10) scale. Intra-op muscle biopsies.

干预措施: Borg CR10 scale (Behavioral)

结局指标

主要结局

Changes between the two group assessed by muscle strength

时间窗: Changes from baseline (pre-op) up to 2 weeks post-op

Test the strength of subject's lower extremity muscles on the dynamometer system

次要结局

  • Changes between the two group assessed by Short Physical Performance Battery (SPPB)(Changes from baseline (pre-op) up to 2 weeks post-op)
  • Changes between the two group assessed by self-assessment outcomes(Changes from baseline (pre-op) up to 2 weeks post-op)
  • Changes between the two group assessed by pain(Changes from baseline (pre-op) up to 2 weeks post-op)
  • Changes between the two group assessed by biological targets on the muscle tissue(Up to 4 hours (end of surgery))
  • Changes between the two group assessed by Six-minute walk (SMW) test(Changes from baseline (pre-op) up to 2 weeks post-op)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验